Viemed Healthcare (VMD)
Viemed Healthcare on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-misc health & allied services, nec.
1.6M
Short interest
settlement 2026-09-30
5.7
Days to cover
+0.4 days vs prior
79.0%
Short share of volume
2026-10-23
711
Fails to deliver
settlement 2026-09-30
Wed 4 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in VMD is 1,569,089 shares, up 361,756 shares over the last month. Over the last 48 readings it ranged from 284,778 shares (29 November 2024) to 1,569,089 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 277K shares a day that is 5.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/vmd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 1,569,089 | +18.5% | 276,955 | 5.67 |
| 2026-09-15 | 1,323,822 | +9.7% | 252,727 | 5.24 |
| 2026-08-31 | 1,207,333 | +53.4% | 430,040 | 2.81 |
| 2026-08-14 | 787,145 | +17.2% | 589,322 | 1.34 |
| 2026-07-31 | 671,738 | -10.1% | 270,103 | 2.49 |
| 2026-07-15 | 747,076 | +43.9% | 313,832 | 2.38 |
| 2026-06-30 | 519,096 | +11.7% | 441,622 | 1.18 |
| 2026-06-15 | 464,553 | -7.6% | 193,872 | 2.40 |
| 2026-05-29 | 502,837 | +23.1% | 215,545 | 2.33 |
| 2026-05-15 | 408,565 | -8.6% | 312,488 | 1.31 |
| 2026-04-30 | 447,066 | +27.2% | 218,701 | 2.04 |
| 2026-04-15 | 351,498 | -10.0% | 284,510 | 1.24 |
| 2026-03-31 | 390,743 | -13.2% | 363,833 | 1.07 |
| 2026-03-13 | 450,066 | +29.5% | 418,682 | 1.07 |
| 2026-02-27 | 347,585 | -2.0% | 144,416 | 2.41 |
| 2026-02-13 | 354,749 | -4.4% | 224,412 | 1.58 |
| 2026-01-30 | 371,241 | +3.6% | 142,006 | 2.61 |
| 2026-01-15 | 358,195 | +10.1% | 121,559 | 2.95 |
| 2025-12-31 | 325,395 | -15.9% | 149,931 | 2.17 |
| 2025-12-15 | 386,808 | -1.7% | 146,821 | 2.63 |
| 2025-11-28 | 393,511 | -3.1% | 155,239 | 2.53 |
| 2025-11-14 | 406,110 | +3.0% | 156,453 | 2.60 |
| 2025-10-31 | 394,458 | +2.7% | 137,833 | 2.86 |
| 2025-10-15 | 384,245 | -4.6% | 188,746 | 2.04 |
| 2025-09-30 | 402,883 | -12.7% | 167,678 | 2.40 |
| 2025-09-15 | 461,415 | +10.2% | 199,128 | 2.32 |
| 2025-08-29 | 418,640 | -1.0% | 248,157 | 1.69 |
| 2025-08-15 | 422,883 | -11.2% | 395,743 | 1.07 |
| 2025-07-31 | 476,153 | +17.3% | 271,946 | 1.75 |
| 2025-07-15 | 405,830 | +5.6% | 161,318 | 2.52 |
| 2025-06-30 | 384,223 | -1.9% | 251,472 | 1.53 |
| 2025-06-13 | 391,655 | +20.1% | 161,305 | 2.43 |
| 2025-05-30 | 326,094 | -3.2% | 134,310 | 2.43 |
| 2025-05-15 | 336,771 | +5.5% | 232,745 | 1.45 |
| 2025-04-30 | 319,204 | -6.1% | 150,943 | 2.11 |
| 2025-04-15 | 339,946 | -14.6% | 124,390 | 2.73 |
| 2025-03-31 | 398,245 | +25.2% | 111,934 | 3.56 |
| 2025-03-14 | 318,130 | +10.5% | 122,132 | 2.60 |
| 2025-02-28 | 287,856 | -3.5% | 97,775 | 2.94 |
| 2025-02-14 | 298,390 | -1.8% | 71,214 | 4.19 |
| 2025-01-31 | 303,768 | -16.8% | 115,426 | 2.63 |
| 2025-01-15 | 365,088 | +6.0% | 144,025 | 2.53 |
| 2024-12-31 | 344,365 | +11.4% | 155,131 | 2.22 |
| 2024-12-13 | 309,205 | +8.6% | 103,072 | 3.00 |
| 2024-11-29 | 284,778 | -2.2% | 117,567 | 2.42 |
| 2024-11-15 | 291,180 | -19.4% | 309,310 | 1.00 |
| 2024-10-31 | 361,182 | +18.4% | 123,856 | 2.92 |
| 2024-10-15 | 305,105 | +48.5% | 192,983 | 1.58 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of VMD volume is 79.0%, up 40.6 points over the last five sessions. Over the last 30 readings it ranged from 38.4% (16 October 2026) to 79.0% (23 October 2026). The latest reading sits at the top of that range. The latest reading is 22.1 points above the 30-session average of 56.9%, on 45K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 36K | 45K | 79.0% | 0 |
| 2026-10-22 | 38K | 57K | 65.9% | 0 |
| 2026-10-21 | 47K | 72K | 65.0% | 0 |
| 2026-10-20 | 46K | 69K | 66.4% | 0 |
| 2026-10-19 | 36K | 70K | 51.1% | 0 |
| 2026-10-16 | 34K | 90K | 38.4% | 0 |
| 2026-10-15 | 35K | 79K | 44.1% | 0 |
| 2026-10-14 | 41K | 65K | 62.4% | 0 |
| 2026-10-13 | 29K | 55K | 52.3% | 0 |
| 2026-10-12 | 27K | 62K | 43.6% | 0 |
| 2026-10-09 | 29K | 56K | 52.3% | 0 |
| 2026-10-08 | 46K | 90K | 50.9% | 0 |
| 2026-10-07 | 50K | 87K | 58.1% | 0 |
| 2026-10-06 | 41K | 75K | 54.2% | 0 |
| 2026-10-05 | 34K | 61K | 56.1% | 0 |
| 2026-10-02 | 47K | 120K | 39.1% | 0 |
| 2026-10-01 | 32K | 71K | 45.2% | 172 |
| 2026-09-30 | 45K | 86K | 52.1% | 269 |
| 2026-09-29 | 59K | 96K | 61.4% | 0 |
| 2026-09-28 | 71K | 156K | 45.6% | 6,700 |
| 2026-09-25 | 51K | 84K | 61.1% | 0 |
| 2026-09-24 | 65K | 93K | 69.8% | 5 |
| 2026-09-23 | 39K | 74K | 51.8% | 0 |
| 2026-09-22 | 65K | 90K | 72.3% | 0 |
| 2026-09-21 | 59K | 100K | 59.0% | 0 |
| 2026-09-18 | 62K | 99K | 62.2% | 0 |
| 2026-09-17 | 86K | 114K | 75.3% | 0 |
| 2026-09-16 | 86K | 121K | 71.0% | 0 |
| 2026-09-15 | 40K | 72K | 55.9% | 0 |
| 2026-09-14 | 43K | 91K | 46.6% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in VMD is 711 shares, up 609 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (2 April 2026) to 85,188 shares (3 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 711 | $9.23 | $7K |
| 2026-09-22 | 102 | $8.85 | $903 |
| 2026-09-11 | 128 | $8.75 | $1K |
| 2026-09-01 | 930 | $8.84 | $8K |
| 2026-08-28 | 2,336 | $9.01 | $21K |
| 2026-08-14 | 2 | $9.17 | $18 |
| 2026-08-13 | 174 | $9.26 | $2K |
| 2026-08-04 | 15,810 | $11.69 | $185K |
| 2026-08-03 | 85,188 | $11.67 | $994K |
| 2026-07-23 | 1 | $11.92 | $12 |
| 2026-07-17 | 10,331 | $12.09 | $125K |
| 2026-07-16 | 118 | $11.88 | $1K |
| 2026-07-02 | 12,054 | $11.74 | $142K |
| 2026-06-04 | 232 | $9.56 | $2K |
| 2026-05-28 | 1,824 | $9.89 | $18K |
| 2026-05-19 | 11,183 | $9.64 | $108K |
| 2026-05-18 | 535 | $9.35 | $5K |
| 2026-05-05 | 4,410 | $9.48 | $42K |
| 2026-04-13 | 62,212 | $9.51 | $592K |
| 2026-04-10 | 1,375 | $9.49 | $13K |
| 2026-04-07 | 7,053 | $9.76 | $69K |
| 2026-04-02 | 1 | $9.59 | $10 |
| 2026-03-26 | 155 | $9.35 | $1K |
| 2026-03-24 | 770 | $9.18 | $7K |
| 2026-03-20 | 118 | $9.22 | $1K |
| 2026-03-10 | 4,590 | $9.29 | $43K |
| 2026-03-06 | 9,589 | $8.40 | $81K |
| 2026-02-09 | 163 | $8.64 | $1K |
| 2026-02-03 | 242 | $8.00 | $2K |
| 2026-02-02 | 242 | $7.67 | $2K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for VMD in the last 90 days. The most recent filings are listed below. Latest filing: Smokoff Timothy (Director) on 2026-08-19.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Smokoff Timothy | Director | Returned to company | 4K | $8.94 | $34K | 91K |
| 2026-08-19 | Smokoff Timothy | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 94K |
| 2026-08-19 | Smokoff Timothy | Director | Exercise or conversion | 15K | price not stated in the filing | not stated | 91K |
| 2026-08-19 | Dobbs Randy E. | Director | Returned to company | 4K | $8.94 | $37K | 142K |
| 2026-08-19 | Dobbs Randy E. | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 146K |
| 2026-08-19 | Dobbs Randy E. | Director | Exercise or conversion | 17K | price not stated in the filing | not stated | 142K |
| 2026-08-19 | Heltz Sabrina | Director | Returned to company | 4K | $8.94 | $34K | 83K |
| 2026-08-19 | Heltz Sabrina | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 86K |
| 2026-08-19 | Heltz Sabrina | Director | Exercise or conversion | 15K | price not stated in the filing | not stated | 83K |
| 2026-08-19 | Kaushal Nitin | Director | Exercise or conversion | 19K | price not stated in the filing | not stated | 161K |
| 2026-06-25 | Frazier William | Chief Medical Officer | Exercise or conversion | 10K | $1.81 | $18K | 83K |
| 2026-06-25 | Frazier William | Chief Medical Officer | Sell | 10K | $11.72 | $117K | 73K |
| 2026-06-24 | Smokoff Timothy | Director | Sell | 5K | $11.41 | $57K | 76K |
| 2026-06-24 | Smokoff Timothy | Director | Sell | 5K | $11.53 | $58K | 81K |
| 2026-06-24 | Smokoff Timothy | Director | Sell | 2K | $11.48 | $19K | 94K |
| 2026-06-24 | Smokoff Timothy | Director | Sell | 5K | $11.56 | $58K | 86K |
| 2026-06-24 | Smokoff Timothy | Director | Sell | 3K | $11.50 | $39K | 91K |
| 2026-03-20 | Moore Michael | President | Sell | 65K | $8.77 | $570K | 1.6M |
| 2026-03-19 | Moore Michael | President | Sell | 40K | $9.21 | $371K | 1.7M |
| 2026-03-18 | Moore Michael | President | Sell | 32K | $9.42 | $297K | 1.7M |
| 2026-01-29 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Exercise or conversion | 27K | price not stated in the filing | not stated | 402K |
| 2026-01-29 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Tax withholding | 11K | $7.48 | $85K | 390K |
| 2026-01-29 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Exercise or conversion | 9K | price not stated in the filing | not stated | 399K |
| 2026-01-29 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Returned to company | 9K | $7.48 | $67K | 390K |
| 2026-01-29 | Fitzgerald Trae | Chief Financial Officer | Returned to company | 3K | $7.48 | $24K | 106K |
| 2026-01-29 | Fitzgerald Trae | Chief Financial Officer | Exercise or conversion | 10K | price not stated in the filing | not stated | 108K |
| 2026-01-29 | Fitzgerald Trae | Chief Financial Officer | Tax withholding | 3K | $7.48 | $20K | 106K |
| 2026-01-29 | Fitzgerald Trae | Chief Financial Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 109K |
| 2026-01-29 | Frazier William | Chief Medical Officer | Tax withholding | 802 | $7.48 | $6K | 73K |
| 2026-01-29 | Frazier William | Chief Medical Officer | Exercise or conversion | 778 | price not stated in the filing | not stated | 74K |
| 2026-01-29 | Frazier William | Chief Medical Officer | Returned to company | 778 | $7.48 | $6K | 73K |
| 2026-01-29 | Frazier William | Chief Medical Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 74K |
| 2026-01-29 | Trahan Jeremy | General Counsel | Exercise or conversion | 11K | price not stated in the filing | not stated | 49K |
| 2026-01-29 | Trahan Jeremy | General Counsel | Tax withholding | 3K | $7.48 | $22K | 46K |
| 2026-01-29 | Trahan Jeremy | General Counsel | Exercise or conversion | 4K | price not stated in the filing | not stated | 50K |
| 2026-01-29 | Trahan Jeremy | General Counsel | Returned to company | 4K | $7.48 | $27K | 46K |
| 2026-01-29 | Moore Michael | President | Tax withholding | 7K | $7.48 | $55K | 189K |
| 2026-01-29 | Moore Michael | President | Exercise or conversion | 27K | price not stated in the filing | not stated | 196K |
| 2026-01-29 | Moore Michael | President | Returned to company | 9K | $7.48 | $67K | 189K |
| 2026-01-29 | Moore Michael | President | Exercise or conversion | 9K | price not stated in the filing | not stated | 198K |
| 2026-01-29 | Cambre Jerome | Vice President of Sales | Exercise or conversion | 9K | price not stated in the filing | not stated | 106K |
| 2026-01-29 | Cambre Jerome | Vice President of Sales | Tax withholding | 2K | $7.48 | $18K | 104K |
| 2026-01-29 | Cambre Jerome | Vice President of Sales | Exercise or conversion | 3K | price not stated in the filing | not stated | 107K |
| 2026-01-29 | Cambre Jerome | Vice President of Sales | Returned to company | 3K | $7.48 | $21K | 104K |
| 2026-01-29 | Hoyt Casey | Chief Executive Officer | Exercise or conversion | 40K | price not stated in the filing | not stated | 364K |
| 2026-01-29 | Hoyt Casey | Chief Executive Officer | Tax withholding | 14K | $7.48 | $104K | 350K |
| 2026-01-29 | Hoyt Casey | Chief Executive Officer | Exercise or conversion | 13K | price not stated in the filing | not stated | 364K |
| 2026-01-29 | Hoyt Casey | Chief Executive Officer | Returned to company | 13K | $7.48 | $99K | 350K |
| 2026-01-21 | Trahan Jeremy | General Counsel | Exercise or conversion | 15K | price not stated in the filing | not stated | 43K |
| 2026-01-21 | Trahan Jeremy | General Counsel | Tax withholding | 5K | $7.49 | $36K | 39K |
| 2026-01-21 | Trahan Jeremy | General Counsel | Returned to company | 4K | $7.49 | $27K | 39K |
| 2026-01-21 | Trahan Jeremy | General Counsel | Exercise or conversion | 4K | price not stated in the filing | not stated | 42K |
| 2026-01-21 | Cambre Jerome | Vice President of Sales | Exercise or conversion | 12K | price not stated in the filing | not stated | 102K |
| 2026-01-21 | Cambre Jerome | Vice President of Sales | Tax withholding | 4K | $7.49 | $29K | 98K |
| 2026-01-21 | Cambre Jerome | Vice President of Sales | Returned to company | 3K | $7.49 | $22K | 98K |
| 2026-01-21 | Cambre Jerome | Vice President of Sales | Exercise or conversion | 3K | price not stated in the filing | not stated | 101K |
| 2026-01-21 | Fitzgerald Trae | Chief Financial Officer | Tax withholding | 4K | $7.49 | $32K | 99K |
| 2026-01-21 | Fitzgerald Trae | Chief Financial Officer | Exercise or conversion | 13K | price not stated in the filing | not stated | 103K |
| 2026-01-21 | Fitzgerald Trae | Chief Financial Officer | Returned to company | 3K | $7.49 | $25K | 99K |
| 2026-01-21 | Fitzgerald Trae | Chief Financial Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 102K |
| 2026-01-21 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Tax withholding | 35K | $7.49 | $263K | 375K |
| 2026-01-21 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Exercise or conversion | 118K | price not stated in the filing | not stated | 410K |
| 2026-01-21 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Returned to company | 9K | $7.49 | $64K | 375K |
| 2026-01-21 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Exercise or conversion | 9K | price not stated in the filing | not stated | 383K |
| 2026-01-21 | Hoyt Casey | Chief Executive Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 337K |
| 2026-01-21 | Hoyt Casey | Chief Executive Officer | Tax withholding | 14K | $7.49 | $102K | 325K |
| 2026-01-21 | Hoyt Casey | Chief Executive Officer | Returned to company | 12K | $7.49 | $93K | 325K |
| 2026-01-21 | Hoyt Casey | Chief Executive Officer | Exercise or conversion | 50K | price not stated in the filing | not stated | 338K |
| 2026-01-21 | Moore Michael | President | Returned to company | 9K | $7.49 | $64K | 170K |
| 2026-01-21 | Moore Michael | President | Exercise or conversion | 9K | price not stated in the filing | not stated | 178K |
| 2026-01-21 | Moore Michael | President | Exercise or conversion | 34K | price not stated in the filing | not stated | 179K |
| 2026-01-21 | Moore Michael | President | Tax withholding | 9K | $7.49 | $70K | 170K |
| 2026-01-21 | Frazier William | Chief Medical Officer | Returned to company | 850 | $7.49 | $6K | 72K |
| 2026-01-21 | Frazier William | Chief Medical Officer | Exercise or conversion | 850 | price not stated in the filing | not stated | 73K |
| 2026-01-21 | Frazier William | Chief Medical Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 73K |
| 2026-01-21 | Frazier William | Chief Medical Officer | Tax withholding | 1K | $7.49 | $9K | 72K |
| 2026-01-17 | Trahan Jeremy | General Counsel | Returned to company | 1K | $7.33 | $9K | 29K |
| 2026-01-17 | Trahan Jeremy | General Counsel | Exercise or conversion | 5K | price not stated in the filing | not stated | 30K |
| 2026-01-17 | Trahan Jeremy | General Counsel | Tax withholding | 2K | $7.33 | $12K | 29K |
| 2026-01-17 | Trahan Jeremy | General Counsel | Exercise or conversion | 1K | price not stated in the filing | not stated | 30K |
| 2026-01-17 | Fitzgerald Trae | Chief Financial Officer | Returned to company | 2K | $7.33 | $18K | 89K |
| 2026-01-17 | Fitzgerald Trae | Chief Financial Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 92K |
| 2026-01-17 | Fitzgerald Trae | Chief Financial Officer | Tax withholding | 3K | $7.33 | $23K | 89K |
| 2026-01-17 | Fitzgerald Trae | Chief Financial Officer | Exercise or conversion | 10K | price not stated in the filing | not stated | 93K |
| 2026-01-17 | Cambre Jerome | Vice President of Sales | Returned to company | 2K | $7.33 | $16K | 90K |
| 2026-01-17 | Cambre Jerome | Vice President of Sales | Exercise or conversion | 9K | price not stated in the filing | not stated | 93K |
| 2026-01-17 | Cambre Jerome | Vice President of Sales | Tax withholding | 3K | $7.33 | $20K | 90K |
| 2026-01-17 | Cambre Jerome | Vice President of Sales | Exercise or conversion | 2K | price not stated in the filing | not stated | 92K |
| 2026-01-17 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Tax withholding | 9K | $7.33 | $63K | 292K |
| 2026-01-17 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Exercise or conversion | 27K | price not stated in the filing | not stated | 301K |
| 2026-01-17 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Exercise or conversion | 7K | price not stated in the filing | not stated | 299K |
| 2026-01-17 | ZEHNDER WILLIAM TODD | Chief Operating Officer | Returned to company | 7K | $7.33 | $49K | 292K |
| 2026-01-17 | Moore Michael | President | Tax withholding | 9K | $7.33 | $63K | 145K |
| 2026-01-17 | Moore Michael | President | Exercise or conversion | 27K | price not stated in the filing | not stated | 153K |
| 2026-01-17 | Moore Michael | President | Returned to company | 7K | $7.33 | $49K | 145K |
| 2026-01-17 | Moore Michael | President | Exercise or conversion | 7K | price not stated in the filing | not stated | 151K |
| 2026-01-17 | Hoyt Casey | Chief Executive Officer | Exercise or conversion | 40K | price not stated in the filing | not stated | 301K |
| 2026-01-17 | Hoyt Casey | Chief Executive Officer | Returned to company | 10K | $7.33 | $73K | 289K |
| 2026-01-17 | Hoyt Casey | Chief Executive Officer | Exercise or conversion | 10K | price not stated in the filing | not stated | 299K |
| 2026-01-17 | Hoyt Casey | Chief Executive Officer | Tax withholding | 12K | $7.33 | $89K | 289K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for VMD worth $1.2M at the prices reported; 0 in the last 90 days worth $0. Latest: MOORE FASTER LLC filed on 2026-03-20 to sell 65,000 shares ($570K) from 2026-03-20.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-03-20 | MOORE FASTER LLCOfficer | 65K | $570K | 0.168% | 2026-03-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-19 | MOORE FASTER LLCOfficer | 40K | $370K | 0.104% | 2026-03-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-18 | MOORE FASTER LLCOfficer | 32K | $297K | 0.082% | 2026-03-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of VMD in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-24 | 13G/Ano. 2 | Forager Capital Management, LLCinvestment adviser | 1.9M | 4.9% | 2026-06-30 |
| 2026-07-24 | 13G/Ano. 2 | Forager Fund, L.P.partnership | 1.9M | 4.9% | 2026-06-30 |
| 2026-07-24 | 13G/Ano. 2 | Kissel Edward Urbanparent holding company, individual | 1.9M | 4.9% | 2026-06-30 |
| 2026-07-24 | 13G/Ano. 2 | MacArthur Robert Symmesparent holding company, individual | 1.9M | 4.9% | 2026-06-30 |
13F holders
Tracked managers holding VMD at their latest 13F. JSON6 of the 30 tracked managers held VMD at their latest 13F, $17.2M in total at quarter-end prices. Two Sigma Investments is the largest at $5.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 439K | $5.0M | 0.00% | +25K |
| Renaissance Technologies | 2026-06-30 | 426K | $4.9M | 0.01% | -16K |
| Citadel Advisors | 2026-06-30 | 234K | $2.7M | 0.00% | +223K |
| AQR Capital Management | 2026-06-30 | 205K | $2.3M | 0.00% | +92K |
| Point72 Asset Management | 2026-06-30 | 156K | $1.8M | 0.00% | +26K |
| Millennium Management | 2026-06-30 | 52K | $592K | 0.00% | +17K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Viemed Healthcare reported revenue of $78.1M, up 23.9% from the same quarter a year earlier, and net income of $2.8M (0.07 diluted EPS). In FY 2025 it generated $51.9M of operating cash flow and spent $13.2M on buybacks. As of 2026-06-30, cash was $10.7M against $6.4M of debt.
- Cash
- $10.7M
- Debt
- $6.4M
- Equity
- $144.0M
- Total assets
- $204.2M
- Shares outstanding
- 38,088,228
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $78.1M | $2.8M | 3.5% | 0.07 |
| Q1 FY 2026 | 2026-03-31 | $75.4M | $2.6M | 3.4% | 0.06 |
| Q4 FY 2025derived | 2025-12-31 | $76.2M | $5.6M | 7.4% | n/a |
| Q3 FY 2025 | 2025-09-30 | $71.9M | $3.5M | 4.9% | 0.09 |
| Q2 FY 2025 | 2025-06-30 | $63.1M | $3.2M | 5.0% | 0.08 |
| Q1 FY 2025 | 2025-03-31 | $59.1M | $2.6M | 4.4% | 0.06 |
| Q4 FY 2024derived | 2024-12-31 | $60.7M | $4.3M | 7.1% | n/a |
| Q3 FY 2024 | 2024-09-30 | $58.0M | $3.9M | 6.7% | 0.10 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $270.3M | $14.9M | $51.9M | $40.0M | $13.2M | n/a |
| FY 2024 | 2024-12-31 | $224.3M | $11.3M | $39.1M | $37.8M | $0 | n/a |
| FY 2023 | 2023-12-31 | $183.0M | $10.2M | $45.2M | $26.1M | $0 | n/a |
| FY 2022 | 2022-12-31 | $138.8M | $6.2M | $27.7M | $22.9M | $9.6M | n/a |
| FY 2021 | 2021-12-31 | $117.1M | $9.1M | $22.5M | $19.7M | $0 | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-27 from the cover page.
What this page is
Viemed Healthcare in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Viemed Healthcare (VMD), SEC CIK 1729149, listed on Nasdaq, classified by the SEC as services-misc health & allied services, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-03-20.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-24.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-03.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-19.JSON and CSV
- Company record
- EDGAR filing index for CIK 1729149Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-misc health & allied services, nec
Other company pages
Datasets
Frequently Asked Questions
How much of VMD is sold short?
1,569,089 shares were held short at the 2026-09-30 settlement, 5.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is VMD's daily short volume?
On 2026-10-23, 35,869 of the 45,386 VMD shares reported to FINRA were sold short, 79.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does VMD have fails to deliver?
The SEC's latest file shows 711 VMD shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are VMD insiders buying or selling?
No open-market insider trades were reported for VMD in the last 90 days. The most recent filings are listed below. Latest filing: Smokoff Timothy (Director) on 2026-08-19.
Have VMD insiders filed to sell?
3 Form 144 notices on file for VMD worth $1.2M at the prices reported; 0 in the last 90 days worth $0. Latest: MOORE FASTER LLC filed on 2026-03-20 to sell 65,000 shares ($570K) from 2026-03-20.
Who owns 5% or more of VMD?
No holder on file reports 5% or more of VMD in its latest filing.
What did VMD report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Viemed Healthcare reported revenue of $78.1M, up 23.9% from the same quarter a year earlier, and net income of $2.8M (0.07 diluted EPS). In FY 2025 it generated $51.9M of operating cash flow and spent $13.2M on buybacks. As of 2026-06-30, cash was $10.7M against $6.4M of debt.
Which tracked 13F managers own VMD?
6 of the 30 tracked 13F managers held VMD shares at their latest filing, $17.2M in all. The largest: Two Sigma Investments (439K shares, $5.0M), Renaissance Technologies (426K shares, $4.9M), Ken Griffin's Citadel Advisors (234K shares, $2.7M), Cliff Asness's AQR Capital Management (205K shares, $2.3M), Steve Cohen's Point72 Asset Management (156K shares, $1.8M), Izzy Englander's Millennium Management (52K shares, $592K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.